These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7692911)

  • 1. [Amniotic and serum alphafetoprotein in the chick embryo with neural tube defect].
    Uriarte S; Barrena MJ; López de Torre B; Aldazábal P; Cuadrado E; Tovar JA
    Cir Pediatr; 1993 Jul; 6(3):137-40. PubMed ID: 7692911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
    Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
    Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of chicken alpha-fetoprotein: a useful tool in studies of embryo development and pathology.
    Uriarte S; Barrena MJ; Lopez de la Torre B; Echaniz P; Tovar JA; Cuadrado E
    J Comp Pathol; 1993 Nov; 109(4):385-93. PubMed ID: 7508955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amniotic and maternal serum alpha-fetoprotein levels of rats with induced neural tube defects.
    Peters PW; Verhoef A; Hagenaars AM
    Acta Morphol Neerl Scand; 1981 Sep; 19(3):205-16. PubMed ID: 6169253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of neural tube defects.
    Dembert ML; Harisiades JP
    Am Fam Physician; 1983 Feb; 27(2):241-4. PubMed ID: 6187201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amniotic fluid glial fibrillary acidic protein (AF-GFAP), a biomarker of open neural tube defects.
    Lopez J; Mikaelian I; Gonzalo P
    Prenat Diagn; 2013 Oct; 33(10):990-5. PubMed ID: 23784867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concanavalin A reactivity pattern of human amniotic fluid AFP examined by crossed affino-immunoelectrophoresis. A definite test for neural tube defect?
    Nørgaard-Pedersen B; Toftager-Larsen K; Philip J; Hindersson P
    Clin Genet; 1980 May; 17(5):355-62. PubMed ID: 6159997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amniotic fluid amino and nucleic acid in normal and neural tube defect pregnancies. A comparison.
    Dawson EB; Harris WA; Evans DR; Van Hook JW
    J Reprod Med; 1999 Jan; 44(1):28-32. PubMed ID: 9987736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic fluid B12, calcium, and lead levels associated with neural tube defects.
    Dawson EB; Evans DR; Harris WA; Van Hook JW
    Am J Perinatol; 1999; 16(7):373-8. PubMed ID: 10614706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spina bifida: a chick embryo experimental model.
    Lopez de Torre B; Tovar JA; Aldazabal P; Uriarte S; Rey A; Ruiz I; San Vicente M
    Z Kinderchir; 1990 Dec; 45 Suppl 1():20-2. PubMed ID: 2293530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid.
    Steen MT; Boddie AM; Fisher AJ; Macmahon W; Saxe D; Sullivan KM; Dembure PP; Elsas LJ
    Prenat Diagn; 1998 Jun; 18(6):545-55. PubMed ID: 9664599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine interference in neurulation: a chick embryo model.
    Afman LA; Blom HJ; Van der Put NM; Van Straaten HW
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):421-8. PubMed ID: 12962286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunochemical determination of amniotic fluid acetylcholinesterase in the antenatal diagnosis of open neural tube defects.
    Loft AG
    Dan Med Bull; 1995 Feb; 42(1):54-70. PubMed ID: 7729170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin A concentration in amniotic fluid and maternal serum related to neural-tube defects.
    Parkinson CE; Tan JC; Gal I
    Br J Obstet Gynaecol; 1982 Nov; 89(11):935-9. PubMed ID: 6184067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maternal serum screening for Down syndrome and neural tube defects].
    van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH
    Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of prenatal diagnosis on NTD surveillance.
    Allen WP; Stevenson RE; Thompson SJ; Dean JH
    Prenat Diagn; 1996 Jun; 16(6):531-5. PubMed ID: 8809894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.